Table 1 Pooled baseline characteristics
Total | Randomized to SGLT2i group | Randomized to control | |
|---|---|---|---|
Sample Size, n | 88,098 | 48,585 | 39,513 |
Age, year | 64.9 ± 9.4 | 64.6 ± 9.4 | 65.2 ± 9.4 |
Male, n (%) | 55,467/88098 (63.0) | 30,318/48585 (62.4) | 25,149/39513 (63.6) |
LVEF, % | 39.2 ± 14.6 | 39.3 ± 14.5 | 39.1 ± 14.7 |
eGFR, ml/min/1.73 m2 | 67.3 ± 23.6 | 67.9 ± 23.5 | 66.6 ± 23.6 |
HF, n (%) | 27,677/80183 (34.5) | 14,327/43370 (33.0) | 13,350/36813 (36.3) |
DM, n (%) | 78,212/88098 (88.8) | 43,643/48585 (89.8) | 34,569/39513 (87.5) |
CKD, n (%) | 14,851/17851 (83.2) | 7614/9107 (83.6) | 7237/8744 (82.8) |
AF, n (%) | 6855/16045 (42.7) | 3441/8024 (42.9) | 3414/8021 (42.6) |
ARNi use n (%) | 1975/27851 (7.1) | 989/13924 (7.1) | 986/13927 (7.1) |